The pathophysiology of diabetes in aging

Research output: Contribution to journalArticle

Abstract

Glucose levels are tightly regulated by the combined function of the muscle to dispose of postprandial glucose, the liver to provide for fasting glucose production, and the β-cells of the pancreas to regulate both by secreting appropriate amounts of insulin. Aging is known to be an insulin resistant state because hyperinsulinemia is required to maintain fasting and postprandial glucose levels in the normal range. Insulin resistance is associated with increases in total and visceral fat mass which are typical of aging. Insulin resistance is also associated with risk factors for accelerated atherosclerosis and coronary artery disease, hypertension and hyperlipidemia. The liver maintains normal glucose levels postprandially and during fasting, but with aging more insulin is required to appropriately regulate hepatic glucose production and avoid hyperglycemia. While β-cell insulin secretion may compensate for the resistance to insulin action of the muscle and liver, elderly subjects with and without obesity may fail to respond by secreting adequate amounts of insulin, and will develop diabetes mellitus. The onset of frank diabetes mellitus is accompanied by further deterioration in muscle, liver, and β-cell function, a phenomenon referred to as 'glucose toxicity.' Understanding the multi-organ pathophysiology of diabetes in the elderly is clinically relevant, because present and future pharmacologic therapies aim to reverse specific organ defects, and often act synergistically to decrease hyperglycemia.

Original languageEnglish (US)
Pages (from-to)5-20
Number of pages16
JournalJournal of Geriatric Drug Therapy
Volume12
Issue number2
StatePublished - 1999

Fingerprint

Glucose
Insulin
Liver
Insulin Resistance
Fasting
Hyperglycemia
Diabetes Mellitus
Muscles
Intra-Abdominal Fat
Hyperinsulinism
Hyperlipidemias
Muscle Cells
Coronary Artery Disease
Pancreas
Atherosclerosis
Reference Values
Obesity
Hypertension
Therapeutics

Keywords

  • Aging
  • Diabetes mellitus
  • Insulin resistance
  • Pathophysiology
  • Visceral fat

ASJC Scopus subject areas

  • Geriatrics and Gerontology
  • Pharmacology (medical)

Cite this

The pathophysiology of diabetes in aging. / Barzilai, Nir; Hawkins, Meredith A.

In: Journal of Geriatric Drug Therapy, Vol. 12, No. 2, 1999, p. 5-20.

Research output: Contribution to journalArticle

@article{e7709dc54bde491a9fa0c2d77708298b,
title = "The pathophysiology of diabetes in aging",
abstract = "Glucose levels are tightly regulated by the combined function of the muscle to dispose of postprandial glucose, the liver to provide for fasting glucose production, and the β-cells of the pancreas to regulate both by secreting appropriate amounts of insulin. Aging is known to be an insulin resistant state because hyperinsulinemia is required to maintain fasting and postprandial glucose levels in the normal range. Insulin resistance is associated with increases in total and visceral fat mass which are typical of aging. Insulin resistance is also associated with risk factors for accelerated atherosclerosis and coronary artery disease, hypertension and hyperlipidemia. The liver maintains normal glucose levels postprandially and during fasting, but with aging more insulin is required to appropriately regulate hepatic glucose production and avoid hyperglycemia. While β-cell insulin secretion may compensate for the resistance to insulin action of the muscle and liver, elderly subjects with and without obesity may fail to respond by secreting adequate amounts of insulin, and will develop diabetes mellitus. The onset of frank diabetes mellitus is accompanied by further deterioration in muscle, liver, and β-cell function, a phenomenon referred to as 'glucose toxicity.' Understanding the multi-organ pathophysiology of diabetes in the elderly is clinically relevant, because present and future pharmacologic therapies aim to reverse specific organ defects, and often act synergistically to decrease hyperglycemia.",
keywords = "Aging, Diabetes mellitus, Insulin resistance, Pathophysiology, Visceral fat",
author = "Nir Barzilai and Hawkins, {Meredith A.}",
year = "1999",
language = "English (US)",
volume = "12",
pages = "5--20",
journal = "Journal of Geriatric Drug Therapy",
issn = "8756-4629",
publisher = "Haworth Press Inc.",
number = "2",

}

TY - JOUR

T1 - The pathophysiology of diabetes in aging

AU - Barzilai, Nir

AU - Hawkins, Meredith A.

PY - 1999

Y1 - 1999

N2 - Glucose levels are tightly regulated by the combined function of the muscle to dispose of postprandial glucose, the liver to provide for fasting glucose production, and the β-cells of the pancreas to regulate both by secreting appropriate amounts of insulin. Aging is known to be an insulin resistant state because hyperinsulinemia is required to maintain fasting and postprandial glucose levels in the normal range. Insulin resistance is associated with increases in total and visceral fat mass which are typical of aging. Insulin resistance is also associated with risk factors for accelerated atherosclerosis and coronary artery disease, hypertension and hyperlipidemia. The liver maintains normal glucose levels postprandially and during fasting, but with aging more insulin is required to appropriately regulate hepatic glucose production and avoid hyperglycemia. While β-cell insulin secretion may compensate for the resistance to insulin action of the muscle and liver, elderly subjects with and without obesity may fail to respond by secreting adequate amounts of insulin, and will develop diabetes mellitus. The onset of frank diabetes mellitus is accompanied by further deterioration in muscle, liver, and β-cell function, a phenomenon referred to as 'glucose toxicity.' Understanding the multi-organ pathophysiology of diabetes in the elderly is clinically relevant, because present and future pharmacologic therapies aim to reverse specific organ defects, and often act synergistically to decrease hyperglycemia.

AB - Glucose levels are tightly regulated by the combined function of the muscle to dispose of postprandial glucose, the liver to provide for fasting glucose production, and the β-cells of the pancreas to regulate both by secreting appropriate amounts of insulin. Aging is known to be an insulin resistant state because hyperinsulinemia is required to maintain fasting and postprandial glucose levels in the normal range. Insulin resistance is associated with increases in total and visceral fat mass which are typical of aging. Insulin resistance is also associated with risk factors for accelerated atherosclerosis and coronary artery disease, hypertension and hyperlipidemia. The liver maintains normal glucose levels postprandially and during fasting, but with aging more insulin is required to appropriately regulate hepatic glucose production and avoid hyperglycemia. While β-cell insulin secretion may compensate for the resistance to insulin action of the muscle and liver, elderly subjects with and without obesity may fail to respond by secreting adequate amounts of insulin, and will develop diabetes mellitus. The onset of frank diabetes mellitus is accompanied by further deterioration in muscle, liver, and β-cell function, a phenomenon referred to as 'glucose toxicity.' Understanding the multi-organ pathophysiology of diabetes in the elderly is clinically relevant, because present and future pharmacologic therapies aim to reverse specific organ defects, and often act synergistically to decrease hyperglycemia.

KW - Aging

KW - Diabetes mellitus

KW - Insulin resistance

KW - Pathophysiology

KW - Visceral fat

UR - http://www.scopus.com/inward/record.url?scp=0032896108&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032896108&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0032896108

VL - 12

SP - 5

EP - 20

JO - Journal of Geriatric Drug Therapy

JF - Journal of Geriatric Drug Therapy

SN - 8756-4629

IS - 2

ER -